Allows pharmacists to transfer Schedule II attention-deficit/hyperactivity disorder prescriptions.
Prohibits pharmacies from charging additional fee for processing prescriptions transmitted by telephone or electronic means.
Prohibits pharmacies from charging additional fee for processing prescriptions transmitted by telephone or electronic means.
Prohibits pharmacies from charging additional fee for processing prescriptions transmitted by telephone or electronic means.
Requires all prescriptions be transmitted electronically, subject to certain exceptions.
Requires all prescriptions be transmitted electronically, subject to certain exceptions.
Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances; requires reporting of xylazine prescriptions.
Regulates Internet pharmacies and electronic prescriptions.
Regulates Internet pharmacies and electronic prescriptions.
Relating to certain procedures applicable to electronic prescriptions for Schedule II controlled substances.